Evidence map›Paper›PMID 30507287›Full record

ArticleJournal of the Royal Society of Medicine2019

Competition in health markets: is something rotten?

Livio Garattini, Anna Padula

Abstract read
In one paragraph

Article in Journal of the Royal Society of Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Public versus private healthcare systems in the OECD area- a broad evaluation of performance.The European journal of health economics : HEPAC : health economics in prevention and care · 2025
    Article
  3. Modeling European health systems: a theoretical exercise.The European journal of health economics : HEPAC : health economics in prevention and care · 2023
    Article
  4. Article
  5. Article
  6. General practice in the EU: countries you see, customs you find.The European journal of health economics : HEPAC : health economics in prevention and care · 2023
    Article
  7. Including mental health care in a model of European health system.Epidemiology and psychiatric sciences · 2023
    Article
  8. The Italian NHS at regional level: same in theory, different in practice.The European journal of health economics : HEPAC : health economics in prevention and care · 2022
    Article
  9. Integrated care: easy in theory, harder in practice?Internal and emergency medicine · 2022
    Article
  10. Pricing vaccines and drugs in Europe: worth differentiating?The European journal of health economics : HEPAC : health economics in prevention and care · 2021
    Article
  11. The Italian NHS in Lombardy and Veneto: near but far.Internal and emergency medicine · 2021
    Article
  12. More room for telemedicine after COVID-19: lessons for primary care?The European journal of health economics : HEPAC : health economics in prevention and care · 2021
    Article
  13. Article
  14. The Italian NHS: What Lessons to Draw from COVID-19?Applied health economics and health policy · 2020
    Article
  15. Defensive medicine in Europe: a 'full circle'?The European journal of health economics : HEPAC : health economics in prevention and care · 2020
    Article
  16. Conflicts of interest in medicine: a never-ending story.Internal and emergency medicine · 2020
    Article
  17. Review
  18. Defensive medicine in Europe: a 'full circle'?The European journal of health economics : HEPAC : health economics in prevention and care · 2020
    Article
  19. Conflict of interest disclosure: striking a balance?The European journal of health economics : HEPAC : health economics in prevention and care · 2019
    Article
  20. An era of caution and careful planning.Journal of the Royal Society of Medicine · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Livio GarattiniCESAV, Centre for Health Economics, Institute for Pharmacological Research Mario Negri IRCCS, Ranica 24020, Italy.
Anna PadulaCESAV, Centre for Health Economics, Institute for Pharmacological Research Mario Negri IRCCS, Ranica 24020, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Economic CompetitionHealth Care SectorHealth ServicesEuropeHumansMarketingMarketing of Health ServicesQuality Improvement

Identifiers

PMID30507287
PMCPMC6348555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.